The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors
Abstract
Vascular diseases, such as hypertension, atherosclerosis, cerebrovascular, and peripheral arterial diseases, present major clinical and public health challenges, largely due to their common underlying process: vascular remodeling. This process involves structural alterations in blood vessels, driven by a variety of molecular mechanisms. The inhibitor of DNA-binding/differentiation-3 (ID3), a crucial member of ID family of transcriptional regulators, has been identified as a key player in vascular biology, significantly impacting the progression of these diseases. This review explores the role of ID3 in vascular remodeling, emphasizing its involvement in processes such as apoptosis, cell proliferation, and extracellular matrix regulation. Furthermore, we examine how oxidative stress, intensified by exposure to estrogenic endocrine disruptors (EEDs) like polychlorinated biphenyls (PCBs) and bisphenol A (BPA), affects ID3 activity and contributes to vascular disease. Understanding the interaction between ID3 signaling and EED exposure provides critical insights into the molecular mechanisms underlying vascular remodeling and its role in the development and progression of vascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Iorga, A., Cunningham, C. M., Moazeni, S., Ruffenach, G., Umar, S., & Eghbali, M. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0152-8 · Cited by 914
Phthalates and other additives in plastics: human exposure and associated health outcomes
Meeker, J. D., Sathyanarayana, S., & Swan, S. H. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0268 · Cited by 835
Endocrine-Disrupting Chemicals and Disease Endpoints
Ahn, C., & Jeung, E.-B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065342 · Cited by 252
Lee, H., Jeung, E., Cho, M., Kim, T., Leung, P. C. K., & Choi, K. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01649.x · Cited by 171
Research works printed but not linked: 109
- Mikolajczyk, 2024, Vascular remodelling in cardiovascular diseases: Hypertension, oxidation, and inflammation, Clin. Sci., 138, 817, 10.1042/CS20220797 · DOI
- Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., and Opie, L. (2014). Lancet Seminar: Cardiovascular Remodelling in Coronary Artery Disease and Heart Failure. Lancet, 383. · DOI · Paper page
- Van Varik, B.J., Rennenberg, R.J.M.W., Reutelingsperger, C.P., Kroon, A.A., De Leeuw, P.W., and Schurgers, L.J. (2012). Mechanisms of arterial remodeling: Lessons from genetic diseases. Front. Genet., 3. · DOI · Paper page
- Melo, 2007, Vascular Remodeling in Health and Disease, Cardiovasc. Med., 50, 1541, 10.1007/978-1-84628-715-2_74 · DOI
- Weissman, 2003, Vascular remodeling: Do we really need yet another study?, J. Am. Coll. Cardiol., 42, 811, 10.1016/S0735-1097(03)00841-6 · doi:10.1016/s0735-1097(03)00841-6
- Carpenter, 2006, Polychlorinated biphenyls (PCBs): Routes of exposure and effects on human health, Rev. Environ. Health, 21, 1, 10.1515/REVEH.2006.21.1.1 · DOI · Paper page
- Rubin, 2011, Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects, J. Steroid Biochem. Mol. Biol., 127, 27, 10.1016/j.jsbmb.2011.05.002 · DOI · Paper page
- Newbold, 2004, Lessons learned from perinatal exposure to diethylstilbestrol, Toxicol. Appl. Pharmacol., 199, 142, 10.1016/j.taap.2003.11.033 · DOI · Paper page
- Kirkley, 2014, Environmental Endocrine Disruption of Energy Metabolism and Cardiovascular Risk, Curr. Diab. Rep., 14, 494, 10.1007/s11892-014-0494-0 · DOI
- Werner, 2015, The association between maternal urinary phthalate concentrations and blood pressure in pregnancy: The HOME Study, Environ. Health, 14, 75, 10.1186/s12940-015-0062-3 · DOI
- Park, 2016, Body burden of persistent organic pollutants on hypertension: A meta-analysis, Environ. Sci. Pollut. Res. Int., 23, 14284, 10.1007/s11356-016-6568-6 · DOI
- Das, J.K., and Felty, Q. (2014). PCB153-induced overexpression of ID3 contributes to the development of microvascular lesions. PLoS ONE, 9. · DOI
- Avecilla, V., Doke, M., and Felty, Q. (2017). Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease. BioMed Res. Int., 2017. · DOI
- Fonseca, 2022, Endocrine-Disrupting Effects of Bisphenol A on the Cardiovascular System: A Review, J. Xenobiotics, 12, 181, 10.3390/jox12030015 · DOI
- Doke, 2018, Abstract 5052: ID3 mediated vascular reprogramming of PCB exposed endothelial cells and its potential contribution to lung tumorigenicity, Cancer Res., 78, 5052, 10.1158/1538-7445.AM2018-5052 · doi:10.1158/1538-7445.am2018-5052
- Doke, M., Felty, Q., and Das, J. (2017). The role of environmental chemical PCB153 in aggressive growth of plexiform lesions associated with lung cancer. Eur. J. Surg. Oncol., 43. · doi:10.1016/j.ejso.2017.10.119
- Wahlang, 2017, Editor’s Highlight: PCB126 Exposure Increases Risk for Peripheral Vascular Diseases in a Liver Injury Mouse Model, Toxicol. Sci., 160, 256, 10.1093/toxsci/kfx180 · DOI
- Felty, 2011, Proteomic 2D DIGE profiling of human vascular endothelial cells exposed to environmentally relevant concentration of endocrine disruptor PCB153 and physiological concentration of 17β-estradiol, Cell Biol. Toxicol., 27, 49, 10.1007/s10565-010-9170-6 · DOI
- Das, J.K., and Felty, Q.H. (2013). Abstract 3899: PCB153-induced angiogenesis depends on redoxsensitive Pyk2 signaling. Cancer Res., 73. · doi:10.1158/1538-7445.am2013-3899
- Doke, M., Avecilla, V., and Felty, Q. (2018). Inhibitor of Differentiation-3 and Estrogenic Endocrine Disruptors: Implications for Susceptibility to Obesity and Metabolic Disorders. BioMed Res. Int., 2018. · DOI
- Vastolo, 2018, High-fat diet unveils an enhancer element at the Ped/Pea-15 gene responsible for epigenetic memory in skeletal muscle, Metabolism, 87, 70, 10.1016/j.metabol.2018.06.001 · DOI
- Ciccarelli, 2016, Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle, Diabetologia, 59, 176, 10.1007/s00125-015-3774-6 · DOI
- Felty, 2008, Estrogen-induced redox sensitive Id3 signaling controls the growth of vascular cells, Atherosclerosis, 198, 12, 10.1016/j.atherosclerosis.2007.12.048 · DOI
- Davignon, 2004, Role of endothelial dysfunction in atherosclerosis, Circulation, 109, III27, 10.1161/01.CIR.0000131515.03336.f8 · DOI · Paper page
- Yilmaz, 2019, Endocrine disrupting chemicals: Exposure, effects on human health, mechanism of action, models for testing and strategies for prevention, Rev. Endocr. Metab. Disord., 21, 127, 10.1007/s11154-019-09521-z · DOI · Paper page
- Poulsen, 2001, Genetic versus environmental aetiology of the metabolic syndrome among male and female twins, Diabetologia, 44, 537, 10.1007/s001250051659 · DOI · Paper page
- Lim, 2005, Molecular mechanisms regulating expression and function of transcription regulator “inhibitor of differentiation 3”, Acta Pharmacol. Sin., 26, 1409, 10.1111/j.1745-7254.2005.00207.x · DOI
- Patti, 2002, Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention, Am. J. Cardiol., 89, 372, 10.1016/S0002-9149(01)02254-8 · doi:10.1016/s0002-9149(01)02254-8
- Sakurai, 2004, Crucial role of inhibitor of DNA binding/differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells, J. Immunol., 173, 5801, 10.4049/jimmunol.173.9.5801 · DOI
- Eelen, 2015, Endothelial cell metabolism in normal and diseased vasculature, Circ. Res., 116, 1231, 10.1161/CIRCRESAHA.116.302855 · DOI · Paper page
- Epstein, 1994, The emerging concept of vascular remodeling, N. Engl. J. Med., 330, 1431, 10.1056/NEJM199405193302008 · DOI · Paper page
- Chakrabarti, 2009, 12/15-Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3-L1 Adipocytes, Obesity, 17, 1657, 10.1038/oby.2009.192 · DOI
- Taylor, 2005, The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth, Arterioscler. Thromb. Vasc. Biol., 25, 2069, 10.1161/01.ATV.0000178992.40088.f2 · doi:10.1161/01.atv.0000178992.40088.f2
- Das, 2015, ID3 Contributes to the Acquisition of Molecular Stem Cell-Like Signature in Microvascular Endothelial Cells: Its implication for understanding microvascular diseases, Microvasc. Res., 98, 126, 10.1016/j.mvr.2015.01.006 · doi:10.1016/j.mvr.2015.01.006
- Funder, J.W. (2017). Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology. Int. J. Mol. Sci., 18. · DOI
- Wassmann, 2010, Interaction of inhibitor of DNA binding 3 (Id3) with Gut-enriched Krüppel-like factor (GKLF) and p53 regulates proliferation of vascular smooth muscle cells, Mol. Cell Biochem., 333, 33, 10.1007/s11010-009-0201-7 · doi:10.1007/s11010-009-0201-7
- Wang, 2024, Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD, Blood, 143, 166, 10.1182/blood.2023021126 · DOI
- Bakr, A., Hey, J., Sigismondo, G., Liu, C.S., Sadik, A., Goyal, A., Cross, A., Iyer, R.L., Müller, P., and Trauernicht, M. (2021). ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition. Nucleic Acids Res., 49. · DOI
- Loveys, 1996, E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein, Nucleic Acids Res., 24, 2813, 10.1093/nar/24.14.2813 · DOI
- Lyden, 1999, Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts, Nature, 401, 670, 10.1038/44334 · DOI · Paper page
- Fishman, 1998, Mechanisms of proliferative and obliterative vascular diseases. Insights from the pulmonary and systemic circulations. NHLBI Workshop summary, Am. J. Respir. Crit. Care Med., 158, 670, 10.1164/ajrccm.158.2.9803084 · DOI
- Fraidenraich, 2004, Rescue of cardiac defects in Id knockout embryos by injection of embryonic stem cells, Science, 306, 247, 10.1126/science.1102612 · DOI · Paper page
- Humphrey, 2021, Vascular Mechanobiology: Homeostasis, Adaptation, and Disease, Annu. Rev. Biomed. Eng., 23, 1, 10.1146/annurev-bioeng-092419-060810 · DOI · Paper page
- Aird, 2012, Endothelial cell heterogeneity, Cold Spring Harb. Perspect. Med., 2, S221, 10.1101/cshperspect.a006429 · DOI · Paper page
- Nakane, 2000, Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction, Hypertension, 35, 595, 10.1161/01.HYP.35.2.595 · DOI
- Sack, 2002, Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease, Pharmacol. Ther., 94, 123, 10.1016/S0163-7258(02)00176-6 · DOI
- Abrams, 1991, Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes, J. Exp. Med., 174, 1209, 10.1084/jem.174.5.1209 · DOI · Paper page
- Briones, 2010, Role of extracellular matrix in vascular remodeling of hypertension, Curr. Opin. Nephrol. Hypertens., 19, 187, 10.1097/MNH.0b013e328335eec9 · DOI
- Min, 2005, Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells, Circ. Res., 97, 434, 10.1161/01.RES.0000180753.63183.95 · DOI · Paper page
- Xu, Q., Zhuo, K., Zhang, X., Zhen, Y., Liu, L., Zhang, L., Gu, Y., Jia, H., Chen, Q., and Liu, M. (2024). The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling. Eur. J. Pharmacol., 962. · DOI
- Doke, M., and Felty, Q.H. (2016). Abstract 3274: VEGF─receptor antagonist, Sugen 5416, sensitizes pulmonary endothelial stem-like cells to estrogens: A microvascular model for the progression of lung cancer. Cancer Res., 76. · doi:10.1158/1538-7445.am2016-3274
- Daugherty, 2004, Angiotensin II-Mediated Development of Vascular Diseases, Trends Cardiovasc. Med., 14, 117, 10.1016/j.tcm.2004.01.002 · DOI
- Savoia, 2006, Inflammation in hypertension, Curr. Opin. Nephrol. Hypertens., 15, 152
- Carey, 2003, The intrarenal renin-angiotensin system and diabetic nephropathy, Trends Endocrinol. Metab., 14, 274, 10.1016/S1043-2760(03)00111-5 · DOI · Paper page
- Forrest, 2004, Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation, J. Biol. Chem., 279, 32897, 10.1074/jbc.M404882200 · DOI
- Deliri, 2011, Increased 12/15-lipoxygenase enhances cell growth, fibronectin deposition, and neointimal formation in response to carotid injury, Arterioscler. Thromb. Vasc. Biol., 31, 110, 10.1161/ATVBAHA.110.212068 · DOI
- Matsumura, 2001, Vascular injury induces posttranscriptional regulation of the Id3 gene: Cloning of a novel Id3 isoform expressed during vascular lesion formation in rat and human atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 21, 752, 10.1161/01.ATV.21.5.752 · DOI
- Mueller, 2002, Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth, Circulation, 105, 2423, 10.1161/01.CIR.0000016047.19488.91 · DOI
- Cutchins, 2012, Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion, Arterioscler. Thromb. Vasc. Biol., 32, 317, 10.1161/ATVBAHA.111.234856 · DOI
- Harmon, 2016, Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance, Arterioscler. Thromb. Vasc. Biol., 36, 682, 10.1161/ATVBAHA.116.307166 · DOI
- Srikakulapu, P., Upadhye, A., Rosenfeld, S.M., Marshall, M.A., McSkimming, C., Hickman, A.W., Mauldin, I.S., Ailawadi, G., Lopes, M.B.S., and Taylor, A.M. (2017). Perivascular adipose tissue harbors atheroprotective IgM-producing B cells. Front. Physiol., 8. · DOI
- Yang, J., Li, X., Li, Y., Southwood, M., Ye, L., Long, L., Al-Lamki, R.S., and Morrell, N.W. (2013). Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol., 305. · DOI
- Mair, 2015, Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells, Am. J. Respir. Crit. Care Med., 191, 693, 10.1164/rccm.201410-1802OC · DOI
- Doran, 2010, Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans, Circ. Res., 106, 1303, 10.1161/CIRCRESAHA.109.210294 · DOI
- Manichaikul, A., Rich, S.S., Perry, H., Yeboah, J., Law, M., Davis, M., Parker, M., Ragosta, M., Connelly, J.J., and McNamara, C.A. (2014). A Functionally Significant Polymorphism in ID3 Is Associated with Human Coronary Pathology. PLoS ONE, 9. · DOI
- Shi, 2017, Systematic analysis of coronary artery disease datasets revealed the potential biomarker and treatment target, Oncotarget, 8, 54583, 10.18632/oncotarget.17426 · doi:10.18632/oncotarget.17426
- Romero, 2013, The angiogenic gene profile of circulating endothelial progenitor cells from ischemic stroke patients, Vasc. Cell, 5, 3, 10.1186/2045-824X-5-3 · DOI
- Chantler, 2017, Stroke-associated pattern of gene expression previously identified by machine-learning is diagnostically robust in an independent patient population, Genom. Data, 14, 47, 10.1016/j.gdata.2017.08.006 · DOI
- Christensen, K.L.Y., and White, P. (2011). A Methodological Approach to Assessing the Health Impact of Environmental Chemical Mixtures: PCBs and Hypertension in the National Health and Nutrition Examination Survey. Int. J. Environ. Res. Public Health, 8. · DOI
- Lind, 2014, Circulating levels of p,p′-DDE are related to prevalent hypertension in the elderly, Environ. Res., 129, 27, 10.1016/j.envres.2013.12.003 · DOI
- Gea, 2015, Association between dietary intake of polychlorinated biphenyls and the incidence of hypertension in a Spanish cohort: The Seguimiento Universidad de Navarra project, Hypertension, 65, 714, 10.1161/HYPERTENSIONAHA.114.04435 · DOI
- Ehrlich, 2024, Data-driven derivation of an adverse outcome pathway linking vascular endothelial growth factor receptor (VEGFR), endocrine disruption, and atherosclerosis, ALTEX Altern. Anim. Exp., 41, 617
- Avecilla, V., Doke, M., Das, M., Alcazar, O., Appunni, S., Rech Tondin, A., Watts, B., Ramamoorthy, V., Rubens, M., and Das, J.K. (2024). Integrative Bioinformatics–Gene Network Approach Reveals Linkage between Estrogenic Endocrine Disruptors and Vascular Remodeling in Peripheral Arterial Disease. Int. J. Mol. Sci., 25. · DOI · Paper page
- Halder, 2023, β1 integrin is essential for blood–brain barrier integrity under stable and vascular remodelling conditions; effects differ with age, Fluids Barriers CNS, 20, 52, 10.1186/s12987-023-00453-0 · DOI
- Evans, B.R., Yerly, A., van der Vorst, E.P.C., Baumgartner, I., Bernhard, S.M., Schindewolf, M., and Döring, Y. (2022). Inflammatory Mediators in Atherosclerotic Vascular Remodeling. Front. Cardiovasc. Med., 9. · DOI
- Liu, 2015, Exposure to coplanar PCBs induces endothelial cell inflammation through epigenetic regulation of NF-κB subunit p65, Toxicol. Appl. Pharmacol., 289, 457, 10.1016/j.taap.2015.10.015 · DOI
- Felty, 2010, Gene expression profile of endothelial cells exposed to estrogenic environmental compounds: Implications to pulmonary vascular lesions, Life Sci., 86, 919, 10.1016/j.lfs.2010.04.007 · DOI
- Shankar, 2012, Peripheral Arterial Disease: Results from the NHANES, Environ. Health Perspect., 120, 1297, 10.1289/ehp.1104114 · DOI · Paper page
- Lin, 2015, Association between levels of serum bisphenol A, a potentially harmful chemical in plastic containers, and carotid artery intima-media thickness in adolescents and young adults, Atherosclerosis, 241, 657, 10.1016/j.atherosclerosis.2015.06.038 · DOI
- Fang, 2015, Bisphenol A exposure induces metabolic disorders and enhances atherosclerosis in hyperlipidemic rabbits, J. Appl. Toxicol., 35, 1058, 10.1002/jat.3103 · DOI
- Hu, 2016, Bisphenol A, an environmental estrogen-like toxic chemical, induces cardiac fibrosis by activating the ERK1/2 pathway, Toxicol. Lett., 250–251, 1, 10.1016/j.toxlet.2016.03.008 · DOI
- Belcher, 2015, Bisphenol A alters autonomic tone and extracellular matrix structure and induces sex-specific effects on cardiovascular function in male and female CD-1 mice, Endocrinology, 156, 882, 10.1210/en.2014-1847 · DOI
- Saura, 2014, Oral administration of bisphenol A induces high blood pressure through angiotensin II/CaMKII-dependent uncoupling of eNOS, FASEB J., 28, 4719, 10.1096/fj.14-252460 · DOI
- Lind, 2011, Circulating levels of bisphenol A and phthalates are related to carotid atherosclerosis in the elderly, Atherosclerosis, 218, 207, 10.1016/j.atherosclerosis.2011.05.001 · DOI · Paper page
- Murphy, 2011, Estrogen signaling and cardiovascular disease, Circ. Res., 109, 687, 10.1161/CIRCRESAHA.110.236687 · DOI · Paper page
- Cleutjens, 2001, 17beta-estradiol attenuates the development of pressure-overload hypertrophy, Circulation, 104, 1419, 10.1161/hc3601.095577 · DOI · Paper page
- Nuedling, 1999, 17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo, Cardiovasc. Res., 43, 666, 10.1016/S0008-6363(99)00093-0 · DOI · Paper page
- Mendelsohn, 2002, Protective effects of estrogen on the cardiovascular system, Am. J. Cardiol., 89, 12, 10.1016/S0002-9149(02)02405-0 · DOI · Paper page
- Umar, 2012, Estrogen paradox in pulmonary hypertension: Current controversies and future perspectives, Am. J. Respir. Crit. Care Med., 186, 125, 10.1164/rccm.201201-0058PP · DOI
- Lahm, 2014, Progress in solving the sex hormone paradox in pulmonary hypertension, Am. J. Physiol. Lung Cell Mol. Physiol., 307, L7, 10.1152/ajplung.00337.2013 · DOI · Paper page
- Das, 2015, Microvascular lesions by estrogen-induced ID3: Its implications in cerebral and cardiorenal vascular disease, J. Mol. Neurosci., 55, 618, 10.1007/s12031-014-0401-9 · DOI
- Felty, 2005, Estrogen, mitochondria, and growth of cancer and non-cancer cells, J. Carcinog., 4, 1, 10.1186/1477-3163-4-1 · DOI
- Hopkins, 2013, Molecular biology of atherosclerosis, Physiol. Rev., 93, 1317, 10.1152/physrev.00004.2012 · DOI · Paper page
- So, B., Park, J., Jang, J., Lim, W., Imdad, S., and Kang, C. (2022). Effect of Aerobic Exercise on Oxidative Stress and Inflammatory Response During Particulate Matter Exposure in Mouse Lungs. Front. Physiol., 12. · DOI
- Wu, L., Xiong, X., Wu, X., Ye, Y., Jian, Z., Zhi, Z., and Gu, L. (2020). Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury. Front. Mol. Neurosci., 13. · DOI · Paper page
- Avecilla, V. (2019). Effect of Transcriptional Regulator ID3 on Pulmonary Arterial Hypertension and Hereditary Hemorrhagic Telangiectasia. Int. J. Vasc. Med., 2019. · DOI
- Yang, 2014, Id proteins in the vasculature: From molecular biology to cardiopulmonary medicine, Cardiovasc. Res., 104, 388, 10.1093/cvr/cvu215 · DOI
- Crosswhite, 2014, Molecular mechanisms of pulmonary arterial remodeling, Mol. Med., 20, 191, 10.2119/molmed.2013.00165 · DOI
- Helsley, R.N., and Zhou, C. (2017). Epigenetic impact of endocrine disrupting chemicals on lipid homeostasis and atherosclerosis: A pregnane X receptor-centric view. Environ. Epigenet., 3. · DOI
- Lința, A.V., Lolescu, B.M., Ilie, C.A., Vlad, M., Blidișel, A., Sturza, A., Borza, C., Muntean, D.M., and Crețu, O.M. (2024). Liver and Pancreatic Toxicity of Endocrine-Disruptive Chemicals: Focus on Mitochondrial Dysfunction and Oxidative Stress. Int. J. Mol. Sci., 25. · DOI
- 2024, Oxidative Stress and Its Biomarkers in Cardiovascular Diseases, Artery Res., 30, 18, 10.1007/s44200-024-00062-8 · DOI
- Mussbacher, M., Derler, M., Basílio, J., and Schmid, J.A. (2023). NF-κB in monocytes and macrophages—An inflammatory master regulator in multitalented immune cells. Front. Immunol., 14. · DOI · Paper page
- Hansen, J.F., Bendtzen, K., Boas, M., Frederiksen, H., Nielsen, C.H., Rasmussen, K., and Feldt-Rasmussen, U. (2015). Influence of Phthalates on Cytokine Production in Monocytes and Macrophages: A Systematic Review of Experimental Trials. PLoS ONE, 10. · DOI
- McDonald, 1997, Activation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils, Blood, 89, 3421, 10.1182/blood.V89.9.3421 · DOI · Paper page
- Guan, 2024, Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis, Curr. Atheroscler. Rep., 26, 411, 10.1007/s11883-024-01220-8 · DOI
- Durham, 2018, Role of smooth muscle cells in vascular calcification: Implications in atherosclerosis and arterial stiffness, Cardiovasc. Res., 114, 590, 10.1093/cvr/cvy010 · DOI · Paper page
- Cao, 2022, How vascular smooth muscle cell phenotype switching contributes to vascular disease, Cell Commun. Signal., 20, 180, 10.1186/s12964-022-00993-2 · DOI · Paper page
- Migliaccio, S., Bimonte, V.M., Besharat, Z.M., Sabato, C., Lenzi, A., Crescioli, C., and Ferretti, E. (2022). Environmental Contaminants Acting as Endocrine Disruptors Modulate Atherogenic Processes: New Risk Factors for Cardiovascular Diseases in Women?. Biomolecules, 12. · doi:10.20944/preprints202111.0300.v1
- Muntean, D.M., Linţa, A.V., Ionică, L.N., Dănilă, M.D., Lighezan, D.F., and Sturza, A. (2024). Vascular Toxicity of Endocrine Disruptors: A Thinly Veiled Threat. Environmental Factors in the Pathogenesis of Cardiovascular Disease, Springer Nature. · DOI
Metadata
- Authors
- Avecilla, V., Doke, M., Appunni, S., Rubens, M., Ramamoorthy, V., & Das, J. K.
- Venue
- Medical Sciences
- Publisher
- MDPI AG
- Published
- 2024-12-26
- Volume
- 13
- Issue
- 1
- Pages
- 2
- ISSN
- 2076-3271
- Cited by
- 5
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.